New Pricing Policies Needed To Curb AMR Impact, States Industry Alliance Report
Medicines For Europe Echoes Report Recommendations
The AMR Industry Alliance has put forward six different policy proposals which it says could minimize the global impact of antimicrobial resistance.
You may also be interested in...
Medicines Patent Pool Centers On Consolidation In Its New Three-Year Strategy
The Medicines Patent Pool’s new strategy could open the door to significant new opportunities for generic drug suppliers across low- and middle-income countries, as it explores its remit in new fields such as biologics, early-stage drug development and even – possibly – antimicrobial resistance.
Medicines for Europe Calls Out Threat Of Generics Supply Consolidation In EU Market
Off-patent drugs industry trade group Medicines for Europe has penned an open letter to the EU containing several suggestions for how the union might tackle supply chain pressures in the generics sector.
Sandoz Pushes Back On AMR And ‘Dysfunctional’ Antibiotics Market
Sandoz CEO Richard Saynor and global head of anti-infectives Ian Ball have spoken out on the threat of antimicrobial resistance and the “increasing dysfunctionality” of the market framework for antibiotics.